APO Research

APO RESEARCH · REPORT

I.V. (Intravenous Fluid) Bags

Selected research

Market Structure

Global I.V. (Intravenous Fluid) Bags Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global I.V. (Intravenous Fluid) Bags market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for I.V. (Intravenous Fluid) Bags is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for I.V. (Intravenous Fluid) Bags is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for I.V. (Intravenous Fluid) Bags is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for I.V. (Intravenous Fluid) Bags is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of I.V. (Intravenous Fluid) Bags include Amcor, Baxter, Fresenius Kabi, Hospira (Pfizer), ICU Medical, Inc., JW Lifescience Corporation, Otsuka Pharmaceutical, SIPPEX and Wihuri Group, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global I.V. (Intravenous Fluid) Bags market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of I.V. (Intravenous Fluid) Bags and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents I.V. (Intravenous Fluid) Bags sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the I.V. (Intravenous Fluid) Bags market size, projected growth trends, production technologies, key applications, and end-use industries.

I.V. (Intravenous Fluid) Bags Segment by Company

Amcor

Baxter

Fresenius Kabi

Hospira (Pfizer)

ICU Medical, Inc.

JW Lifescience Corporation

Otsuka Pharmaceutical

SIPPEX

Wihuri Group

B. Braun

I.V. (Intravenous Fluid) Bags Segment by Type

Polyolefin IV Bags

PVC (polyvinyl chloride) IV Bags

Others

I.V. (Intravenous Fluid) Bags Segment by Application

Veterinary Medicine

Drug Delivery

Healthcare

I.V. (Intravenous Fluid) Bags Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global I.V. (Intravenous Fluid) Bags market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of I.V. (Intravenous Fluid) Bags and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of I.V. (Intravenous Fluid) Bags.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the I.V. (Intravenous Fluid) Bags market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of I.V. (Intravenous Fluid) Bags manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of I.V. (Intravenous Fluid) Bags in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of I.V. (Intravenous Fluid) Bags in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. I.V. (Intravenous Fluid) Bags Industry Trends Table 2. I.V. (Intravenous Fluid) Bags Industry Drivers Table 3. I.V. (Intravenous Fluid) Bags Industry Opportunities and Challenges Table 4. I.V. (Intravenous Fluid) Bags Industry Restraints Table 5. Global I.V. (Intravenous Fluid) Bags Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global I.V. (Intravenous Fluid) Bags Revenue Market Share by Manufacturers (2021-2026) Table 7. Global I.V. (Intravenous Fluid) Bags Sales by Manufacturers (Units) & (2021-2026) Table 8. Global I.V. (Intravenous Fluid) Bags Sales Market Share by Manufacturers Table 9. Global I.V. (Intravenous Fluid) Bags Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global I.V. (Intravenous Fluid) Bags Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global I.V. (Intravenous Fluid) Bags Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global I.V. (Intravenous Fluid) Bags Manufacturers, Product Type & Application Table 13. Global I.V. (Intravenous Fluid) Bags Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global I.V. (Intravenous Fluid) Bags by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Polyolefin IV Bags Table 17. Major Manufacturers of PVC (polyvinyl chloride) IV Bags Table 18. Major Manufacturers of Others Table 19. Global I.V. (Intravenous Fluid) Bags Sales by Type 2021 VS 2025 VS 2032 (Units) Table 20. Global I.V. (Intravenous Fluid) Bags Sales by Type (2021-2026) & (Units) Table 21. Global I.V. (Intravenous Fluid) Bags Sales by Type (2027-2032) & (Units) Table 22. Global I.V. (Intravenous Fluid) Bags Sales Market Share by Type (2021-2026) Table 23. Global I.V. (Intravenous Fluid) Bags Sales Market Share by Type (2027-2032) Table 24. Global I.V. (Intravenous Fluid) Bags Revenue by Type 2021 VS 2025 VS 2032 (Units) Table 25. Global I.V. (Intravenous Fluid) Bags Revenue by Type (2021-2026) & (Units) Table 26. Global I.V. (Intravenous Fluid) Bags Revenue by Type (2027-2032) & (Units) Table 27. Global I.V. (Intravenous Fluid) Bags Revenue Market Share by Type (2021-2026) Table 28. Global I.V. (Intravenous Fluid) Bags Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Veterinary Medicine Table 30. Major Manufacturers of Drug Delivery Table 31. Major Manufacturers of Healthcare Table 32. Global I.V. (Intravenous Fluid) Bags Sales by Application 2021 VS 2025 VS 2032 (Units) Table 33. Global I.V. (Intravenous Fluid) Bags Sales by Application (2021-2026) & (Units) Table 34. Global I.V. (Intravenous Fluid) Bags Sales by Application (2027-2032) & (Units) Table 35. Global I.V. (Intravenous Fluid) Bags Sales Market Share by Application (2021-2026) Table 36. Global I.V. (Intravenous Fluid) Bags Sales Market Share by Application (2027-2032) Table 37. Global I.V. (Intravenous Fluid) Bags Revenue by Application 2021 VS 2025 VS 2032 (Units) Table 38. Global I.V. (Intravenous Fluid) Bags Revenue by Application (2021-2026) & (Units) Table 39. Global I.V. (Intravenous Fluid) Bags Revenue by Application (2027-2032) & (Units) Table 40. Global I.V. (Intravenous Fluid) Bags Revenue Market Share by Application (2021-2026) Table 41. Global I.V. (Intravenous Fluid) Bags Revenue Market Share by Application (2027-2032) Table 42. Global I.V. (Intravenous Fluid) Bags Sales by Region: 2021 VS 2025 VS 2032 (Units) Table 43. Global I.V. (Intravenous Fluid) Bags Sales by Region (2021-2026) & (Units) Table 44. Global I.V. (Intravenous Fluid) Bags Sales Market Share by Region (2021-2026) Table 45. Global I.V. (Intravenous Fluid) Bags Sales Forecasted by Region (2027-2032) & (Units) Table 46. Global I.V. (Intravenous Fluid) Bags Sales Forecasted Market Share by Region (2027-2032) Table 47. North America I.V. (Intravenous Fluid) Bags Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 48. North America I.V. (Intravenous Fluid) Bags Sales by Country (2021-2026) & (Units) Table 49. North America I.V. (Intravenous Fluid) Bags Sales by Country (2027-2032) & (Units) Table 50. Europe I.V. (Intravenous Fluid) Bags Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 51. Europe I.V. (Intravenous Fluid) Bags Sales by Country (2021-2026) & (Units) Table 52. Europe I.V. (Intravenous Fluid) Bags Sales by Country (2027-2032) & (Units) Table 53. Asia Pacific I.V. (Intravenous Fluid) Bags Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 54. Asia Pacific I.V. (Intravenous Fluid) Bags Sales by Country (2021-2026) & (Units) Table 55. Asia Pacific I.V. (Intravenous Fluid) Bags Sales by Country (2027-2032) & (Units) Table 56. South America, Middle East and Africa I.V. (Intravenous Fluid) Bags Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 57. South America, Middle East and Africa I.V. (Intravenous Fluid) Bags Sales by Country (2021-2026) & (Units) Table 58. South America, Middle East and Africa I.V. (Intravenous Fluid) Bags Sales by Country (2027-2032) & (Units) Table 59. Global I.V. (Intravenous Fluid) Bags Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global I.V. (Intravenous Fluid) Bags Revenue by Region (2021-2026) & (US$ Million) Table 61. Global I.V. (Intravenous Fluid) Bags Revenue by Region (2027-2032) & (US$ Million) Table 62. Global I.V. (Intravenous Fluid) Bags Revenue Market Share by Region (2021-2026) Table 63. Global I.V. (Intravenous Fluid) Bags Revenue Market Share by Region (2027-2032) Table 64. Amcor Company Information Table 65. Amcor Business Overview Table 66. Amcor I.V. (Intravenous Fluid) Bags Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Amcor I.V. (Intravenous Fluid) Bags Product Portfolio Table 68. Amcor Recent Development Table 69. Baxter Company Information Table 70. Baxter Business Overview Table 71. Baxter I.V. (Intravenous Fluid) Bags Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Baxter I.V. (Intravenous Fluid) Bags Product Portfolio Table 73. Baxter Recent Development Table 74. Fresenius Kabi Company Information Table 75. Fresenius Kabi Business Overview Table 76. Fresenius Kabi I.V. (Intravenous Fluid) Bags Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Fresenius Kabi I.V. (Intravenous Fluid) Bags Product Portfolio Table 78. Fresenius Kabi Recent Development Table 79. Hospira (Pfizer) Company Information Table 80. Hospira (Pfizer) Business Overview Table 81. Hospira (Pfizer) I.V. (Intravenous Fluid) Bags Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Hospira (Pfizer) I.V. (Intravenous Fluid) Bags Product Portfolio Table 83. Hospira (Pfizer) Recent Development Table 84. ICU Medical, Inc. Company Information Table 85. ICU Medical, Inc. Business Overview Table 86. ICU Medical, Inc. I.V. (Intravenous Fluid) Bags Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. ICU Medical, Inc. I.V. (Intravenous Fluid) Bags Product Portfolio Table 88. ICU Medical, Inc. Recent Development Table 89. JW Lifescience Corporation Company Information Table 90. JW Lifescience Corporation Business Overview Table 91. JW Lifescience Corporation I.V. (Intravenous Fluid) Bags Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. JW Lifescience Corporation I.V. (Intravenous Fluid) Bags Product Portfolio Table 93. JW Lifescience Corporation Recent Development Table 94. Otsuka Pharmaceutical Company Information Table 95. Otsuka Pharmaceutical Business Overview Table 96. Otsuka Pharmaceutical I.V. (Intravenous Fluid) Bags Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Otsuka Pharmaceutical I.V. (Intravenous Fluid) Bags Product Portfolio Table 98. Otsuka Pharmaceutical Recent Development Table 99. SIPPEX Company Information Table 100. SIPPEX Business Overview Table 101. SIPPEX I.V. (Intravenous Fluid) Bags Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. SIPPEX I.V. (Intravenous Fluid) Bags Product Portfolio Table 103. SIPPEX Recent Development Table 104. Wihuri Group Company Information Table 105. Wihuri Group Business Overview Table 106. Wihuri Group I.V. (Intravenous Fluid) Bags Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Wihuri Group I.V. (Intravenous Fluid) Bags Product Portfolio Table 108. Wihuri Group Recent Development Table 109. B. Braun Company Information Table 110. B. Braun Business Overview Table 111. B. Braun I.V. (Intravenous Fluid) Bags Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. B. Braun I.V. (Intravenous Fluid) Bags Product Portfolio Table 113. B. Braun Recent Development Table 114. Key Raw Materials Table 115. Raw Materials Key Suppliers Table 116. I.V. (Intravenous Fluid) Bags Distributors List Table 117. I.V. (Intravenous Fluid) Bags Customers List Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. I.V. (Intravenous Fluid) Bags Product Image Figure 2. Global I.V. (Intravenous Fluid) Bags Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global I.V. (Intravenous Fluid) Bags Market Size (2021-2032) & (US$ Million) Figure 4. Global I.V. (Intravenous Fluid) Bags Sales (2021-2032) & (Units) Figure 5. Global I.V. (Intravenous Fluid) Bags Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 I.V. (Intravenous Fluid) Bags Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Polyolefin IV Bags Image Figure 9. PVC (polyvinyl chloride) IV Bags Image Figure 10. Others Image Figure 11. Global I.V. (Intravenous Fluid) Bags Sales by Type (2021 VS 2025 VS 2032) & (Units) Figure 12. Global I.V. (Intravenous Fluid) Bags Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global I.V. (Intravenous Fluid) Bags Sales Market Share by Type (2021-2032) Figure 14. Global I.V. (Intravenous Fluid) Bags Revenue by Type (2021 VS 2025 VS 2032) & (Units) Figure 15. Global I.V. (Intravenous Fluid) Bags Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global I.V. (Intravenous Fluid) Bags Revenue Market Share by Type (2021-2032) Figure 17. Veterinary Medicine Image Figure 18. Drug Delivery Image Figure 19. Healthcare Image Figure 20. Global I.V. (Intravenous Fluid) Bags Sales by Application (2021 VS 2025 VS 2032) & (Units) Figure 21. Global I.V. (Intravenous Fluid) Bags Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global I.V. (Intravenous Fluid) Bags Sales Market Share by Application (2021-2032) Figure 23. Global I.V. (Intravenous Fluid) Bags Revenue by Application (2021 VS 2025 VS 2032) & (Units) Figure 24. Global I.V. (Intravenous Fluid) Bags Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global I.V. (Intravenous Fluid) Bags Revenue Market Share by Application (2021-2032) Figure 26. North America I.V. (Intravenous Fluid) Bags Sales and Growth Rate (2021-2032) & (Units) Figure 27. North America I.V. (Intravenous Fluid) Bags Sales Market Share by Country (2021-2032) Figure 28. U.S. I.V. (Intravenous Fluid) Bags Sales and Growth Rate (2021-2032) & (Units) Figure 29. Canada I.V. (Intravenous Fluid) Bags Sales and Growth Rate (2021-2032) & (Units) Figure 30. Mexico I.V. (Intravenous Fluid) Bags Sales and Growth Rate (2021-2032) & (Units) Figure 31. Europe I.V. (Intravenous Fluid) Bags Sales and Growth Rate (2021-2032) & (Units) Figure 32. Europe I.V. (Intravenous Fluid) Bags Sales Market Share by Country (2021-2032) Figure 33. Germany I.V. (Intravenous Fluid) Bags Sales and Growth Rate (2021-2032) & (Units) Figure 34. France I.V. (Intravenous Fluid) Bags Sales and Growth Rate (2021-2032) & (Units) Figure 35. U.K. I.V. (Intravenous Fluid) Bags Sales and Growth Rate (2021-2032) & (Units) Figure 36. Italy I.V. (Intravenous Fluid) Bags Sales and Growth Rate (2021-2032) & (Units) Figure 37. Netherlands I.V. (Intravenous Fluid) Bags Sales and Growth Rate (2021-2032) & (Units) Figure 38. Asia Pacific I.V. (Intravenous Fluid) Bags Sales and Growth Rate (2021-2032) & (Units) Figure 39. Asia Pacific I.V. (Intravenous Fluid) Bags Sales Market Share by Country (2021-2032) Figure 40. China I.V. (Intravenous Fluid) Bags Sales and Growth Rate (2021-2032) & (Units) Figure 41. Japan I.V. (Intravenous Fluid) Bags Sales and Growth Rate (2021-2032) & (Units) Figure 42. South Korea I.V. (Intravenous Fluid) Bags Sales and Growth Rate (2021-2032) & (Units) Figure 43. Southeast Asia I.V. (Intravenous Fluid) Bags Sales and Growth Rate (2021-2032) & (Units) Figure 44. India I.V. (Intravenous Fluid) Bags Sales and Growth Rate (2021-2032) & (Units) Figure 45. Australia I.V. (Intravenous Fluid) Bags Sales and Growth Rate (2021-2032) & (Units) Figure 46. South America, Middle East and Africa I.V. (Intravenous Fluid) Bags Sales and Growth Rate (2021-2032) & (Units) Figure 47. South America, Middle East and Africa I.V. (Intravenous Fluid) Bags Sales Market Share by Country (2021-2032) Figure 48. Brazil I.V. (Intravenous Fluid) Bags Sales and Growth Rate (2021-2032) & (Units) Figure 49. South Africa I.V. (Intravenous Fluid) Bags Sales and Growth Rate (2021-2032) & (Units) Figure 50. Saudi Arabia I.V. (Intravenous Fluid) Bags Sales and Growth Rate (2021-2032) & (Units) Figure 51. Turkey I.V. (Intravenous Fluid) Bags Sales and Growth Rate (2021-2032) & (Units) Figure 52. Argentina I.V. (Intravenous Fluid) Bags Sales and Growth Rate (2021-2032) & (Units) Figure 53. UAE I.V. (Intravenous Fluid) Bags Sales and Growth Rate (2021-2032) & (Units) Figure 54. Egypt I.V. (Intravenous Fluid) Bags Sales and Growth Rate (2021-2032) & (Units) Figure 55. Chile I.V. (Intravenous Fluid) Bags Sales and Growth Rate (2021-2032) & (Units) Figure 56. Global I.V. (Intravenous Fluid) Bags Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global I.V. (Intravenous Fluid) Bags Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America I.V. (Intravenous Fluid) Bags Revenue (2021-2032) & (US$ Million) Figure 59. North America I.V. (Intravenous Fluid) Bags Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe I.V. (Intravenous Fluid) Bags Revenue (2021-2032) & (US$ Million) Figure 61. Europe I.V. (Intravenous Fluid) Bags Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific I.V. (Intravenous Fluid) Bags Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific I.V. (Intravenous Fluid) Bags Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa I.V. (Intravenous Fluid) Bags Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa I.V. (Intravenous Fluid) Bags Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. I.V. (Intravenous Fluid) Bags Value Chain Figure 67. Manufacturing Cost Structure Figure 68. I.V. (Intravenous Fluid) Bags Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Polyolefin IV Bags
  • PVC (polyvinyl chloride) IV Bags
  • Others
Applications
  • Veterinary Medicine
  • Drug Delivery
  • Healthcare
Companies covered
  • Amcor
  • Baxter
  • Fresenius Kabi
  • Hospira (Pfizer)
  • ICU Medical, Inc.
  • JW Lifescience Corporation
  • Otsuka Pharmaceutical
  • SIPPEX
  • Wihuri Group
  • B. Braun

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global I.V. (Intravenous Fluid) Bags Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global I.V. (Intravenous Fluid) Bags Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global I.V. (Intravenous Fluid) Bags Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global I.V. (Intravenous Fluid) Bags Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global I.V. (Intravenous Fluid) Bags Market Dynamics
  1. 2.1 I.V. (Intravenous Fluid) Bags Industry Trends
  2. 2.2 I.V. (Intravenous Fluid) Bags Industry Drivers
  3. 2.3 I.V. (Intravenous Fluid) Bags Industry Opportunities and Challenges
  4. 2.4 I.V. (Intravenous Fluid) Bags Industry Restraints
3 I.V. (Intravenous Fluid) Bags Market by Manufacturers
  1. 3.1 Global I.V. (Intravenous Fluid) Bags Revenue by Manufacturers (2021-2026)
  2. 3.2 Global I.V. (Intravenous Fluid) Bags Sales by Manufacturers (2021-2026)
  3. 3.3 Global I.V. (Intravenous Fluid) Bags Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global I.V. (Intravenous Fluid) Bags Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global I.V. (Intravenous Fluid) Bags Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global I.V. (Intravenous Fluid) Bags Manufacturers, Product Type & Application
  7. 3.7 Global I.V. (Intravenous Fluid) Bags Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global I.V. (Intravenous Fluid) Bags Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 I.V. (Intravenous Fluid) Bags Players Market Share by Revenue in 2025
  11. 3.8.3 2025 I.V. (Intravenous Fluid) Bags Tier 1, Tier 2, and Tier 3
4 I.V. (Intravenous Fluid) Bags Market by Type
  1. 4.1 I.V. (Intravenous Fluid) Bags Type Introduction
  2. 4.1.1 Polyolefin IV Bags
  3. 4.1.2 PVC (polyvinyl chloride) IV Bags
  4. 4.1.3 Others
  5. 4.2 Global I.V. (Intravenous Fluid) Bags Sales by Type
  6. 4.2.1 Global I.V. (Intravenous Fluid) Bags Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global I.V. (Intravenous Fluid) Bags Sales by Type (2021-2032)
  8. 4.2.3 Global I.V. (Intravenous Fluid) Bags Sales Market Share by Type (2021-2032)
  9. 4.3 Global I.V. (Intravenous Fluid) Bags Revenue by Type
  10. 4.3.1 Global I.V. (Intravenous Fluid) Bags Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global I.V. (Intravenous Fluid) Bags Revenue by Type (2021-2032)
  12. 4.3.3 Global I.V. (Intravenous Fluid) Bags Revenue Market Share by Type (2021-2032)
5 I.V. (Intravenous Fluid) Bags Market by Application
  1. 5.1 I.V. (Intravenous Fluid) Bags Application Introduction
  2. 5.1.1 Veterinary Medicine
  3. 5.1.2 Drug Delivery
  4. 5.1.3 Healthcare
  5. 5.2 Global I.V. (Intravenous Fluid) Bags Sales by Application
  6. 5.2.1 Global I.V. (Intravenous Fluid) Bags Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global I.V. (Intravenous Fluid) Bags Sales by Application (2021-2032)
  8. 5.2.3 Global I.V. (Intravenous Fluid) Bags Sales Market Share by Application (2021-2032)
  9. 5.3 Global I.V. (Intravenous Fluid) Bags Revenue by Application
  10. 5.3.1 Global I.V. (Intravenous Fluid) Bags Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global I.V. (Intravenous Fluid) Bags Revenue by Application (2021-2032)
  12. 5.3.3 Global I.V. (Intravenous Fluid) Bags Revenue Market Share by Application (2021-2032)
6 Global I.V. (Intravenous Fluid) Bags Sales by Region
  1. 6.1 Global I.V. (Intravenous Fluid) Bags Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global I.V. (Intravenous Fluid) Bags Sales by Region (2021-2032)
  3. 6.2.1 Global I.V. (Intravenous Fluid) Bags Sales by Region (2021-2026)
  4. 6.2.2 Global I.V. (Intravenous Fluid) Bags Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America I.V. (Intravenous Fluid) Bags Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America I.V. (Intravenous Fluid) Bags Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe I.V. (Intravenous Fluid) Bags Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe I.V. (Intravenous Fluid) Bags Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific I.V. (Intravenous Fluid) Bags Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific I.V. (Intravenous Fluid) Bags Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa I.V. (Intravenous Fluid) Bags Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa I.V. (Intravenous Fluid) Bags Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global I.V. (Intravenous Fluid) Bags Revenue by Region
  1. 7.1 Global I.V. (Intravenous Fluid) Bags Revenue by Region
  2. 7.1.1 Global I.V. (Intravenous Fluid) Bags Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global I.V. (Intravenous Fluid) Bags Revenue by Region (2021-2026)
  4. 7.1.3 Global I.V. (Intravenous Fluid) Bags Revenue by Region (2027-2032)
  5. 7.1.4 Global I.V. (Intravenous Fluid) Bags Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America I.V. (Intravenous Fluid) Bags Revenue (2021-2032)
  8. 7.2.2 North America I.V. (Intravenous Fluid) Bags Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe I.V. (Intravenous Fluid) Bags Revenue (2021-2032)
  11. 7.3.2 Europe I.V. (Intravenous Fluid) Bags Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific I.V. (Intravenous Fluid) Bags Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific I.V. (Intravenous Fluid) Bags Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa I.V. (Intravenous Fluid) Bags Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa I.V. (Intravenous Fluid) Bags Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Amcor
  2. 8.1.1 Amcor Company Information
  3. 8.1.2 Amcor Business Overview
  4. 8.1.3 Amcor I.V. (Intravenous Fluid) Bags Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Amcor I.V. (Intravenous Fluid) Bags Product Portfolio
  6. 8.1.5 Amcor Recent Developments
  7. 8.2 Baxter
  8. 8.2.1 Baxter Company Information
  9. 8.2.2 Baxter Business Overview
  10. 8.2.3 Baxter I.V. (Intravenous Fluid) Bags Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Baxter I.V. (Intravenous Fluid) Bags Product Portfolio
  12. 8.2.5 Baxter Recent Developments
  13. 8.3 Fresenius Kabi
  14. 8.3.1 Fresenius Kabi Company Information
  15. 8.3.2 Fresenius Kabi Business Overview
  16. 8.3.3 Fresenius Kabi I.V. (Intravenous Fluid) Bags Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Fresenius Kabi I.V. (Intravenous Fluid) Bags Product Portfolio
  18. 8.3.5 Fresenius Kabi Recent Developments
  19. 8.4 Hospira (Pfizer)
  20. 8.4.1 Hospira (Pfizer) Company Information
  21. 8.4.2 Hospira (Pfizer) Business Overview
  22. 8.4.3 Hospira (Pfizer) I.V. (Intravenous Fluid) Bags Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Hospira (Pfizer) I.V. (Intravenous Fluid) Bags Product Portfolio
  24. 8.4.5 Hospira (Pfizer) Recent Developments
  25. 8.5 ICU Medical, Inc.
  26. 8.5.1 ICU Medical, Inc. Company Information
  27. 8.5.2 ICU Medical, Inc. Business Overview
  28. 8.5.3 ICU Medical, Inc. I.V. (Intravenous Fluid) Bags Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 ICU Medical, Inc. I.V. (Intravenous Fluid) Bags Product Portfolio
  30. 8.5.5 ICU Medical, Inc. Recent Developments
  31. 8.6 JW Lifescience Corporation
  32. 8.6.1 JW Lifescience Corporation Company Information
  33. 8.6.2 JW Lifescience Corporation Business Overview
  34. 8.6.3 JW Lifescience Corporation I.V. (Intravenous Fluid) Bags Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 JW Lifescience Corporation I.V. (Intravenous Fluid) Bags Product Portfolio
  36. 8.6.5 JW Lifescience Corporation Recent Developments
  37. 8.7 Otsuka Pharmaceutical
  38. 8.7.1 Otsuka Pharmaceutical Company Information
  39. 8.7.2 Otsuka Pharmaceutical Business Overview
  40. 8.7.3 Otsuka Pharmaceutical I.V. (Intravenous Fluid) Bags Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Otsuka Pharmaceutical I.V. (Intravenous Fluid) Bags Product Portfolio
  42. 8.7.5 Otsuka Pharmaceutical Recent Developments
  43. 8.8 SIPPEX
  44. 8.8.1 SIPPEX Company Information
  45. 8.8.2 SIPPEX Business Overview
  46. 8.8.3 SIPPEX I.V. (Intravenous Fluid) Bags Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 SIPPEX I.V. (Intravenous Fluid) Bags Product Portfolio
  48. 8.8.5 SIPPEX Recent Developments
  49. 8.9 Wihuri Group
  50. 8.9.1 Wihuri Group Company Information
  51. 8.9.2 Wihuri Group Business Overview
  52. 8.9.3 Wihuri Group I.V. (Intravenous Fluid) Bags Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Wihuri Group I.V. (Intravenous Fluid) Bags Product Portfolio
  54. 8.9.5 Wihuri Group Recent Developments
  55. 8.10 B. Braun
  56. 8.10.1 B. Braun Company Information
  57. 8.10.2 B. Braun Business Overview
  58. 8.10.3 B. Braun I.V. (Intravenous Fluid) Bags Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 B. Braun I.V. (Intravenous Fluid) Bags Product Portfolio
  60. 8.10.5 B. Braun Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 I.V. (Intravenous Fluid) Bags Value Chain Analysis
  2. 9.1.1 I.V. (Intravenous Fluid) Bags Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 I.V. (Intravenous Fluid) Bags Production Mode & Process
  6. 9.2 I.V. (Intravenous Fluid) Bags Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 I.V. (Intravenous Fluid) Bags Distributors
  9. 9.2.3 I.V. (Intravenous Fluid) Bags Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research